ClinicalTrials.gg
RecruitingNCT07378189OFAPPUpdated Sep 4, 2026

Opioid-free Anesthesia as an Alternative to General Anesthesia in Patients Undergoing Laparoscopic Peripheral Pancreatic Resection

An interventional study of Opioid Free Anesthesia (OFA) and Balanced anesthesia with opioids in Pain Management, sponsored by Jagiellonian University. Recruiting at 2 sites in Poland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Jagiellonian University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 97 studies in Pain with a site in Poland — 9 open to participants now, 9 under way, none of them phase 3. Pain · Poland.

Planned enrollment
44th of 89
200 · median 200
Started
2026
with 3 others
No phase
26 of 97
4 open now
Registered
94th of 97
by date
Lead sponsor
6 of 97
Jagiellonian University

Among the 97 studies in Pain with a site in Poland, this one is the 44th largest by planned enrollment of the 89 interventional ones that give a count, is one of 4 that started in 2026, is one of 26 with no phase, and was the 94th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

9 of the 97 studies in Pain with a site in Poland are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies in Pain with a site in Poland, or all of them as a file.
02

Study summary

Opioid-free anesthesia is not associated with greater pain than opioid anesthesia and is associated with reduced postoperative pain.

Read the detailed description

In our study, the investigators would like to compare the measurement of total oxycodone consumption in the postoperative period in both groups and whether the use of opioid-free anesthesia would reduce opioid consumption by 30%. The secondary objective will be to assess pain in both groups during the first 48 postoperative hours in patients undergoing pancreatic surgery. Patients would be randomly assigned to anesthesia with and without opioids at 1, 2, 6, 12, 24, and 48 hours after surgery. Other secondary objectives include assessing the incidence of postoperative nausea and vomiting (PONV), adverse drug reactions, particularly cardiac arrhythmias, and the impact on persistent postoperative pain. On day 7 after surgery, each patient will receive the QOR-15 questionnaire to assess quality of life and the PQA-10 questionnaire.

03

Conditions studied

  • Pain Management

Browse trials for

Keywords

  • Pain
  • OFA
  • Opioid Free Anesthesia
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient consent to participate in the study
  • Qualified for laparoscopic peripheral pancreatic resection
  • Age 18-80 years
  • and III

Exclusion criteria

Exclusion Criteria:

  • Patient refusal to participate in the study
  • Inability to operate a PCA pump
  • Lack of understanding of the NRS scale
  • to anesthetics
  • First- or second-degree heart block.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Balanced anesthesia with opioids

    Patients who will have pancreatic operation under balanced anesthesia including opioids

    Drug: Balanced anesthesia with opioids

  • Experimental
    Opioid Free Anesthesia (OFA)

    Patients who willl have pancreatic operation under Opioid Free anesthesia

    Other: Opioid Free Anesthesia (OFA)

Interventions

  • OtherOpioid Free Anesthesia (OFA)

    Patients who will have pancreatic operation under Opioid Free anesthesia

  • DrugBalanced anesthesia with opioids

    Patients who will hav pancreatic operation under balanced anesthesia including opioids

06

What researchers measure

Primary outcomes

  1. Opioid consumption

    measurement of total oxycodone consumption in the postoperative period

    Time frame: up to 48 hours after surgery

Secondary outcomes

  1. Pain assessment

    Assessment of pain at 1, 2, 6, 12, 24, and 48 hours after surgery by NRS scale (0-10, 0 - no pain, 10 worst pain imaginable)

    Time frame: at 1, 2, 6, 12, 24, and 48 hours after surgery

  2. PONV

    assessment of the occurrence of postoperative nausea and vomiting (PONV)

    Time frame: up to 48 h after surgery

  3. Quality Of Recovery

    QOR-15 questionnaire to assess quality of life and PQA-10 questionnaire. The QOR-15 is a 15 items questionnaire which provides a valid and efficient evaluation of the postoperative quality of recovery. The QoR 15 score is a score of 15 items, each scored from 0 to 10. These items assess 5 dimensions of post-operative recovery: pain, physical comfort, functional autonomy, emotions and psychological support. These 15 items represent the quality of post-operative rehabilitation in its physical and mental dimensions

    Time frame: on the 7th day after surgery

07

Study locations

2 of 2 sites recruiting
  • Department of Intensive Interdisciplinary Care, Collegium Medicum, Jagiellonian University
    Krakow, Lesser Poland Voivodeship 30-688, Poland
    Recruiting
  • University Hospital in Cracow
    Krakow, Lesser Poland Voivodeship 30-688, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — ndividual participant data (IPD) will be shared contingent upon obtaining appropriate consent from the study participants. Data will be made available only in accordance with applicable ethical and regulatory requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2027, 15 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 15 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 25, 2025
First posted
Jan 30, 2026
StartActual
Sep 2, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07378189
Responsible party
Tomasz Skladzien (older asistent, Jagiellonian University) — Principal investigator
First posted
Jan 30, 2026
Start date
Sep 2, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 4, 2026

Study contacts

Michal Cicio, MD
Contact
michal.cicio@uj.edu.pl
124001800 ext. +48

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion